Correlation Between Nubeva Technologies and Telo Genomics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Nubeva Technologies and Telo Genomics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Nubeva Technologies and Telo Genomics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Nubeva Technologies and Telo Genomics Corp, you can compare the effects of market volatilities on Nubeva Technologies and Telo Genomics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Nubeva Technologies with a short position of Telo Genomics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Nubeva Technologies and Telo Genomics.

Diversification Opportunities for Nubeva Technologies and Telo Genomics

0.61
  Correlation Coefficient

Poor diversification

The 3 months correlation between Nubeva and Telo is 0.61. Overlapping area represents the amount of risk that can be diversified away by holding Nubeva Technologies and Telo Genomics Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Telo Genomics Corp and Nubeva Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Nubeva Technologies are associated (or correlated) with Telo Genomics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Telo Genomics Corp has no effect on the direction of Nubeva Technologies i.e., Nubeva Technologies and Telo Genomics go up and down completely randomly.

Pair Corralation between Nubeva Technologies and Telo Genomics

Assuming the 90 days trading horizon Nubeva Technologies is expected to generate 0.62 times more return on investment than Telo Genomics. However, Nubeva Technologies is 1.62 times less risky than Telo Genomics. It trades about 0.03 of its potential returns per unit of risk. Telo Genomics Corp is currently generating about 0.01 per unit of risk. If you would invest  22.00  in Nubeva Technologies on August 26, 2024 and sell it today you would lose (1.00) from holding Nubeva Technologies or give up 4.55% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthSignificant
Accuracy100.0%
ValuesDaily Returns

Nubeva Technologies  vs.  Telo Genomics Corp

 Performance 
       Timeline  
Nubeva Technologies 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Nubeva Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain fairly stable which may send shares a bit higher in December 2024. The latest fuss may also be a sign of long-term up-swing for the venture sophisticated investors.
Telo Genomics Corp 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Telo Genomics Corp has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's technical and fundamental indicators remain nearly stable which may send shares a bit higher in December 2024. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Nubeva Technologies and Telo Genomics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Nubeva Technologies and Telo Genomics

The main advantage of trading using opposite Nubeva Technologies and Telo Genomics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Nubeva Technologies position performs unexpectedly, Telo Genomics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Telo Genomics will offset losses from the drop in Telo Genomics' long position.
The idea behind Nubeva Technologies and Telo Genomics Corp pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

Alpha Finder
Use alpha and beta coefficients to find investment opportunities after accounting for the risk
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Portfolio File Import
Quickly import all of your third-party portfolios from your local drive in csv format